Abstract:Problem: According to the guidelines, acute vulvovaginal candidosis (VVC) may be treated vaginally, through a combination of vaginal treatment and cream for the vulva or orally. However, there is a lack of investigations into whether combined treatment for the vagina and vulva achieves better results than vaginal treatment alone. Method: In 1999, 160 patients with vulvovaginal candidosis from ten German gynaecological practices were included in a study and treated on a randomised basis with three 200 mg clotrimazol vaginal suppositories = clotrimazol 2 % cream (verum n = 79) or + placebo (active-ingredient-free cream base n = 79). The examinations took place before treatment (T1), six to eight days following the end of treatment (T2) and approximately four weeks following the end of treatment (T3). In addition to demographic data, the clinical findings of each investigation were documented in a standardised way and a native preparation and a fungal culture were taken. The doctor and patient evaluated the healing process and tolerance. The main efficacy variables were the pre/post difference scores for extravaginal redness. Results: On T1, there was no difference between the two groups. By T2, there was a significant difference in the extent of extravaginal redness between the verum and the placebo groups (p = 0.0002), as well as in the subgroup of the per-protocol analysis (verum 64, placebo 70 patients, p = 0.0015). Genital itching or burning had entirely disappeared in 51 % and 56 % of patients respectively in the verum group and in only 30 % and 45 % of patients in the placebo group on T2 (p = 0.0181). There was no difference in intravaginal redness on T1 and T2 in either group. The overall assessment by the doctor went accordingly (p = 0.0004). On T1, the extravaginal fungal culture was positive in 75 women in the verum group and in 76 women in the placebo group. On T2, however, this was positive in 51.9 % (verum) and 73.1 % (placebo) of cases, and a positive culture was evinced in the vagina in 6 vs. 8 women (7.5 vs. 10.1 %, p = 0.3802). The local tolerance in both groups was 70 % very good, and 29 vs. 27 % good. After four weeks (T3), 16 out of 23 patients in the verum group and only 8 out of 21 in the placebo group had negative extravaginal fungal cultures. Discussion: There is a lack of studies into the issue of whether vaginal treatment or combined vulvovaginal treatment of acute VVC would be more advantageous. However, there are two studies that support the significant results of this paper that when it comes to acute VVC, the combination of three 200 mg clotrimazol vaginal suppositories with clotrimazol cream 2 % is better than with vaginal suppositories alone.

Single-Dose Therapy of Vaginal Mycosis with Clotrimazol (500 mg) Vaginal Tablet: A Pharmacoeconomic Study

The Efficacy and Safety of Clotrimazole Vaginal Tablet Vs. Oral Fluconazole in Treating Severe Vulvovaginal Candidiasis.

[A Multicenter, Randomized, Open and Positive Parallel Controlled Clinical Study of Clotrimazole Vaginal Expansion Suppository and Vaginal Tablet in the Treatment of Mild and Moderate Vulvovaginal Candidiasis].

Miconazole Nitrate Vaginal Suppository 1,200 Mg Versus Oral Fluconazole 150 Mg in Treating Severe Vulvovaginal Candidiasis

Three-Day Combination Treatment for Vulvovaginal Candidosis with 200 mg Clotrimazol Vaginal Suppositories and Clotrimazol Cream for the Vulva is Significantly Better than Treatment with Vaginal Suppositories Alone - an Earlier, Multi-Centre, Placebo-Controlled Double Blind Study

Clinical Effect and Safety of Miconazole Nitrate 1200 Mg in Treating Vulvovaginal Candidiasis

Improved Treatment of Vulvovaginal Candidiasis with Clotrimazole Plus Probiotic Lacidophilin Vaginal Capsules: A Prospective, Real-World Study.

A Randomized Clinical Trial of the Efficacy and Safety of Terconazole Vaginal Suppository Versus Oral Fluconazole for Treating Severe Vulvovaginal Candidiasis.

A Three Day Study with Miconazole Ovula 400mg and Cream in Vulvovaginal Candidiasis

Chamomile Extract versus Clotrimazole Vaginal Cream in Treatment of Vulvovaginal Candidiasis: A Randomized Double-Blind Control Trial

Comparison of Effects of Miconazolenitrate Suppository on Recurrent Vulvovaginal Candidiasis

Three-Dose Antifungal Treatment Improves the Efficacy for Severe Vulvovaginal Candidiasis

Contrast Study of Cost - Effectiveness of 4 Therapeutic Regimens for Treatment of Trichomonal Vaginitis

The Efficacy and Safety of Miconazole Nitrate Mucoadhesive Tablets Versus Itraconazole Capsules in the Treatment of Oral Candidiasis: an Open-Label, Randomized, Multicenter Trial.

Clotrimazole-induced shifts in vaginal bacteriome and lipid metabolism: insights into recovery mechanisms in vulvovaginal candidiasis

Observation of the Comprehensive Efficacy of Ozone Combined with Clotrimazole in the Treatment of Fungal Vaginitis

Comparison among the clinical curative effects using different 5'-nitroimidazole drugs in treating anaerobic or trichomonal vaginitis

Cost-effectiveness Analysis of 3 Kinds of Therapeutic Regimes in the Treatment of Bacterial Vaginitis

The efficacy of complementary treatment with marshmallow (Althaea officinalis L.) on vulvovaginal candidiasis: A randomized double-blinded controlled clinical trial

Correlation of In Vitro Miconazole Nitrate Sesceptibilty with Clinical Outcome for Complicated Vulvovaginal Candidiasis

Clinical effective observation of 80 cases on miconazole nitrate capsule 400 mg in 3-days treatment of vulvovaginal candidiasis